Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2012, Trends, Share, Size Research Report

GlobalData's clinical trial report, Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2012" provides data on the Cutaneous T-Cell Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cutaneous T-Cell Lymphoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cutaneous T-Cell Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 7

Introduction 8
Cutaneous T-Cell Lymphoma 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Cutaneous T-Cell Lymphoma 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
BioCryst Pharmaceuticals, Inc. 33
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Kyowa Hakko Kirin Co., Ltd. 35
Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 35
Eisai Inc. 36
Clinical Trial Overview of Eisai Inc. 36
TopoTarget A/S 37
Clinical Trial Overview of TopoTarget A/S 37
Centocor Research and Development 38
Clinical Trial Overview of Centocor Research and Development 38
Minophagen Pharmaceutical Co., Ltd. 39
Clinical Trial Overview of Minophagen Pharmaceutical Co., Ltd. 39
TSD Japan, Inc. 40
Clinical Trial Overview of TSD Japan, Inc. 40
Transgene SA 41
Clinical Trial Overview of Transgene SA 41
Johnson & Johnson 42
Clinical Trial Overview of Johnson & Johnson 42
Allos Therapeutics, Inc. 43
Clinical Trial Overview of Allos Therapeutics, Inc. 43
Ligand Pharmaceuticals, Inc. 44
Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 44
Celgene Corporation 45
Clinical Trial Overview of Celgene Corporation 45
Cyclacel Pharmaceuticals Inc. 46
Clinical Trial Overview of Cyclacel Pharmaceuticals Inc. 46
Genmab A/S 47
Clinical Trial Overview of Genmab A/S 47
Therakos, Inc. 48
Clinical Trial Overview of Therakos, Inc. 48
Merck & Co., Inc. 49
Clinical Trial Overview of Merck & Co., Inc. 49
Eli Lilly and Company 50
Clinical Trial Overview of Eli Lilly and Company 50
Clinical Trial Overview of Top Universities / Institutes / Hospitals 51
Fred Hutchinson Cancer Research Center 51
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 51
Stanford University 52
Clinical Trial Overview of Stanford University 52
The University of Texas M. D. Anderson Cancer Center 53
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 53
University of Alabama at Birmingham 54
Clinical Trial Overview of University of Alabama at Birmingham 54
University of Pittsburgh 55
Clinical Trial Overview of University of Pittsburgh 55
Robert H. Lurie Comprehensive Cancer Center of Northwestern University 56
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University 56
European Organization for Research and Treatment of Cancer 57
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 57
Memorial Sloan Kettering Cancer Center 58
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 58
Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS 59
Clinical Trial Overview of Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS 59
Mayo Clinic 60
Clinical Trial Overview of Mayo Clinic 60
University of Medicine and Dentistry New Jersey 61
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 61
Boston University 62
Clinical Trial Overview of Boston University 62
Fox Chase Cancer Center 63
Clinical Trial Overview of Fox Chase Cancer Center 63
UCLA's Jonsson Comprehensive Cancer Center 64
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center 64
Dartmouth-Hitchcock Medical Center 65
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 65
FUDAN University 66
Clinical Trial Overview of FUDAN University 66
Simmons Cancer Center 67
Clinical Trial Overview of Simmons Cancer Center 67
Northwestern University 68
Clinical Trial Overview of Northwestern University 68
University of California, Los Angeles 69
Clinical Trial Overview of University of California, Los Angeles 69
Case Comprehensive Cancer Center 70
Clinical Trial Overview of Case Comprehensive Cancer Center 70
Five Key Clinical Profiles 71

Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 101

List of Table

Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, G7 Countries, 2012* 18
Cutaneous T-Cell Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, E7 Countries, 2012* 20
Cutaneous T-Cell Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by BioCryst Pharmaceuticals, Inc., 2012* 33
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 34
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyowa Hakko Kirin Co., Ltd., 2012* 35
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 36
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by TopoTarget A/S, 2012* 37
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Centocor Research and Development, 2012* 38
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Minophagen Pharmaceutical Co., Ltd., 2012* 39
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by TSD Japan, Inc., 2012* 40
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Transgene SA, 2012* 41
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 42
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Allos Therapeutics, Inc., 2012* 43
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ligand Pharmaceuticals, Inc., 2012* 44
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 45
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cyclacel Pharmaceuticals Inc., 2012* 46
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genmab A/S, 2012* 47
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Therakos, Inc., 2012* 48
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 49
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 50
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 51
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 52
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 53
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2012* 54
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 55
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2012* 56
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 57
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 58
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Groupe Ouest Est d'Etude des Leucemies et Autres Maladies du Sang GOELAMS, 2012* 59
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 60
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 61
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2012* 62
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2012* 63
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012* 64
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dartmouth-Hitchcock Medical Center, 2012* 65
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 66
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Simmons Cancer Center, 2012* 67
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 68
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2012* 69
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012* 70

List of Chart

Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Cutaneous T-Cell Lymphoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Cutaneous T-Cell Lymphoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Cutaneous T-Cell Lymphoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
GlobalData Methodology 99

Ask for discount before buying this report

Please fill the enquiry form below.

Full Name *
Your Email *
Job Title
Company *
Phone No. * (Pls. Affix Country Code)
Country :

Your Requirement
Security Code *
67155

* denotes fields which must be completed

Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2012

List of Table

List of Chart

Buy This Report

Have Query?

Research Assistance